WYPH Stock Overview
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
WayPoint Biomedical Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0003 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| WYPH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 1.2% |
| 1Y | n/a | -0.7% | 24.7% |
Return vs Industry: Insufficient data to determine how WYPH performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how WYPH performed against the US Market.
Price Volatility
| WYPH volatility | |
|---|---|
| WYPH Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: WYPH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine WYPH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Steven Fox | n/a |
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction.
WayPoint Biomedical Holdings, Inc. Fundamentals Summary
| WYPH fundamental statistics | |
|---|---|
| Market cap | US$30.00 |
| Earnings (TTM) | -US$806.27k |
| Revenue (TTM) | US$33.24k |
0.0x
P/S Ratio0.0x
P/E RatioIs WYPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WYPH income statement (TTM) | |
|---|---|
| Revenue | US$33.24k |
| Cost of Revenue | US$48.61k |
| Gross Profit | -US$15.37k |
| Other Expenses | US$790.90k |
| Earnings | -US$806.27k |
Last Reported Earnings
Jun 30, 2006
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did WYPH perform over the long term?
See historical performance and comparison